tirzepatide sermorelin GLP-1, NAD+ & Wellness Plans Medical Weight Loss | The

[DOI] [PMC free article] [PubMed] [Google Scholar] 31.Cariou B

A new generation of these medications has transformed treatment possibilities for people who have type 2 diabetes (Ozempic, Mounjaro) or who have obesity or are overweight with a related health condition (Wegovy, Zepbound, Foundayo)

A BMI of 30 or above typically qualifies you for GLP-1 weight loss injections

M., Abbasi, B., Hakam, N., & Breyer, B

Diabetes is an established risk factor for cardiovascular events such as stroke that is evaluated in cardiovascular outcome trials, with non-fatal stroke representing one of the three components of major adverse cardiovascular events (MACE)

If you prefer smaller injection volumes, use 1 mL for a 10 mg/mL concentration instead